Image

Europe Respiratory Diagnostics Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Jul 2022
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Medical Devices
  • Upcoming Report
  • Jul 2022
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Respiratory Diagnostics Market, By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2029

Europe Respiratory Diagnostics Market

Europe Respiratory Diagnostics Market Analysis and Size

The Europe respiratory diagnostics market is expected to witness significant growth during the forecast period. The global respiratory diagnostics market has been treading on a healthy growth path. Respiratory diagnostics consists of a principal part in the therapeutic innovation area. The rising prevalence of respiratory diseases has set a major concern for accurate disease diagnosis and hence paved the way for the respiratory diagnostics market growth.

Data Bridge Market Research analyses a growth rate in the Europe respiratory diagnostics market in the forecast period 2022-2029. The expected CAGR of Europe respiratory diagnostics market is tend to be around 7.40% in the mentioned forecast period. The market was valued at USD 1.92 billion in 2021, and it would grow upto USD 3.4 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Respiratory diagnostics play a significant role in the medical technology sector. It entails the clinical evaluation of various respiratory conditions such as bronchitis, asthma, COPD, and pulmonary fibrosis, among others, using various mechanical, imaging, and molecular diagnostic tests. Spirometry, computed tomography, oximetry, transcutaneous carbon dioxide monitoring, chest X-ray, sniff nasal inspiratory pressure (SNIP), and other types of respiratory diagnostics are included. Various technological advancements in respiratory diagnostic testing have paved the way for market growth, including the incorporation of artificial intelligence and the use of the internet of things (IoT), among others.

Europe Respiratory Diagnostics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other)

Countries Covered

U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe

Market Players Covered

BD (U.S.), COSMED srl (Italy), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), MGC Diagnostics Corporation (U.S.), Masimo (U.S.), bioMérieux SA (France), Carestream Health  (U.S.), VYAIRE (U.S.), Seegene Inc.(South Korea) and ResMed (U.S.)

Market Opportunities

  • Increased Geriatric Population

Europe Respiratory Diagnostics Market Dynamics

Drivers

  • Growing Rate of Diseases

The rising prevalence of tuberculosis and lung cancer are driving the market growth at a fast pace. In 2020, many more people died from TB, with far fewer people being diagnosed and treated or provided with TB preventive treatment compared with 2019, and overall spending on essential TB services falling.

  • Higher Demand of Hospitals

The rising demand of hospitals increase the market growth rapidly. Most respiratory disease diagnostics are majorly carried out in hospitals as they are very complex and it requires technologically advanced products and thus this is driving the market for hospital/clinical laboratories.

Opportunities

  • Increased Geriatric Population

The rising number of elderly population and associated comorbid conditions such as cough issues, deteriorating respiratory conditions, community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease and non-pneumonic respiratory tract infection tend to create opportunities of Europe respiratory diagnostics market.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to use these diagnostic techniques could curb the growth of the Europe respiratory diagnostics market over a forecast period.

  • High Cost

The huge expenditure required for setting up these techniques surely hamper the market growth. Several market players make huge investment in installing new and advanced machines to faster the process and in return the cost is increased.

This Europe respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Europe Respiratory Diagnostics Market

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.

In the post-pandemic era, COVID-19 is expected to positively impact the ultr low freezers market, attributing to the increasing number of biobanks and plasma treatments.  

Europe Respiratory Diagnostics Market Scope

The Europe respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

Test Type

  • Traditional Diagnostic Tests
  • Mechanical Tests
  • Imaging Tests
  • Molecular Diagnostic Tests

Diseases

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Asthma
  • Tuberculosis
  • Bronchitis
  • Pulmonary Fibrosis
  • Other Diseases

End User

  • Hospital/Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Other

 Europe Respiratory Diagnostics Market Regional Analysis/Insights

The Europe respiratory diagnostics market is analysed and market size insights and trends are provided by product and services, test type, diseases, end-user and distribution channel as referenced above.

The major countries covered in the respiratory diagnostics market report are the U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany's respiratory diagnostics market is expanding primarily as a result of increased focus on the high prevalence of disorders among the elderly. Rising social media concerns are also significant growth drivers for the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Europe Respiratory Diagnostics Market Share Analysis

The Europe respiratory diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe respiratory diagnostics market

Key players operating in the Europe respiratory diagnostics market include:

  • BD (U.S.)
  • COSMED srl (Italy)
  • Abbott (U.S.)
  • NIHON KOHDEN CORPORATION (Japan)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • GENERAL ELECTRIC COMPANY (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • MGC Diagnostics Corporation (U.S.)
  • Masimo (U.S.)
  • bioMérieux SA (France)
  • Carestream Health  (U.S.)
  • VYAIRE (U.S.)
  • Seegene Inc. (South Korea)
  • ResMed (U.S.)


SKU-
Why Choose Us


Frequently Asked Questions

The Europe Respiratory Diagnostics Market is expected USD 3.4 billion by 2029.
The Europe Respiratory Diagnostics Market is projected to grow at a CAGR of 7.40% during the forecast period of 2022-2029.
The major players operating in the Europe Respiratory Diagnostics Market are BD (U.S.), COSMED srl (Italy), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), MGC Diagnostics Corporation (U.S.), Masimo (U.S.), bioMérieux SA (France), Carestream Health (U.S.), VYAIRE (U.S.), Seegene Inc.(South Korea) and ResMed (U.S.).
The major countries covered in the Europe Respiratory Diagnostics Market are U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.